Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(33%)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Terminated(1)
Other(1)

Detailed Status

Completed1
unknown1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
50.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed133%
unknown133%
terminated133%

Recent Activity

0 active trials
Showing 3 of 3
terminatednot_applicable

Efficacy of TBCT, MBHP and PPT for PTSD During the Covid-19 Pandemics

NCT04852770
unknownnot_applicable

CBT and Quality of Life of People With HIV, COVID-19 and Anxiety or Depression

NCT05185921
completednot_applicable

Cognitive Therapy in Patients Failing ART

NCT03751046

Clinical Trials (3)

Showing 3 of 3 trials
NCT04852770Not Applicable

Efficacy of TBCT, MBHP and PPT for PTSD During the Covid-19 Pandemics

Terminated
NCT05185921Not Applicable

CBT and Quality of Life of People With HIV, COVID-19 and Anxiety or Depression

Unknown
NCT03751046Not Applicable

Cognitive Therapy in Patients Failing ART

Completed

All 3 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
3